This multifunctional role of SLPI makes it interesting from a therapeutic point of view, as altering this system could potentially reduce over-exaggerated proteolytic activity in inflammatory lung diseases such as COPD and CF, modulate the inflammatory response, and protect these patients from bacterial infections [38]. The gene discussed is SLPI; the disease is chronic obstructive pulmonary disease.